Navigation Links
Cepheid Reports Fourth Quarter and Full Year 2010 Results
Date:1/27/2011

SUNNYVALE, Calif., Jan. 27, 2011 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today reported revenue for the fourth quarter of 2010 of $58.7 million.  Net income was $1.3 million, or $0.02 per fully diluted share, which compares to revenue of $49.2 million and a net loss of $4.3 million, or $(0.07) per share, in the fourth quarter of fiscal 2009.  Excluding amortization of purchased intangible assets and stock compensation expenses, non-GAAP net income for the fourth quarter of fiscal 2010 was $6.1 million, or $0.09 per fully diluted share.  This compares to a non-GAAP net income of $0.3 million, or $0.01 per fully diluted share, in the fourth quarter of fiscal 2009.

Fiscal 2010 OverviewFor the full fiscal year ended December 31, 2010, Cepheid reported revenue of $212.5 million which compares to revenue of $170.6 million in 2009.  Net loss for the full year was $5.9 million, or $(0.10) per share, which compares to a net loss of $22.5 million, or $(0.39) per share, in 2009.  Excluding amortization of purchased intangible assets and stock compensation expenses, non-GAAP net income for the full year was $12.5 million, or $0.20 per fully diluted share.  This compares to a non-GAAP net loss, which excludes amortization of purchased intangible assets, stock compensation expenses and restructuring expenses, of $5.0 million, or $(0.09) per share, for the full year 2009.

"As we enter 2011, awareness of Cepheid's technology leadership and the unique capabilities of our GeneXpert® system has never been higher, with more than 1,800 systems placed globally and our broadest test menu ever," said John Bishop, Cepheid's Chief Executive Officer.  "Strong market adoption of our growing Xpert® test menu was a significant driver for our success in 2010 and is expected to continue in 2011."

Operational Overview

  • Fourth quarter
    '/>"/>

  • SOURCE Cepheid
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
    2. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
    3. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
    4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
    5. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
    6. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
    7. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
    8. Cepheid Reports 2009 Third Quarter Results
    9. Cepheid to Webcast Upcoming Financial Presentations
    10. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
    11. Cepheid to Webcast Upcoming Financial Presentation
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)...  Vermillion, Inc. (NASDAQ: VRML ), a ... health, has appointed Holly B. Bauzon as ... Ms. Bauzon has a proven track record in both ... services companies. She has more than 20 years of ... held the position of Director, Lab Services Sales and ...
    (Date:8/21/2014)... 21, 2014  Publicis Groupe customer engagement agency ... Partner and Healthcare Industry Group Leader, has been featured ... the most inspiring people in the life-sciences industry. Those ... and development, marketing, technology, creativity, strategy and medicine. ... a partner in its leading Rosetta Consulting practice. In ...
    (Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ... Equipment, Inc. for the third straight year, No. ... 500|5000, an exclusive ranking of the nation,s fastest-growing ... look at the most important segment of the ... Timberland, Dell, Domino,s Pizza, LinkedIn, Zillow, and many ...
    Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2Shannon Hartley Shines in PharmaVOICE 100 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3
    ... , ZURICH, Aug. 27 /PRNewswire/ -- Nycomed ... four phase III trials have been published in the prestigious peer-reviewed medical ... a phosphodiesterase 4 (PDE4) inhibitor, improved lung function and reduced exacerbations in ... COPD is an under-diagnosed progressive lung disease that may lead to ...
    ... , , ... WaveSense blood glucose meters, announced today their continued commitment to ... blood glucose meter (BGM) accuracy for all patients. WaveSense BGM,s ... world class accuracy. They detect and correct for errors caused ...
    Cached Medicine Technology:Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 2Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 3Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 4Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 5Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 6Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 7Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 8Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduces Exacerbations 9WaveSense Diabetes Products Safe from Maltose Inaccuracy Risks 2WaveSense Diabetes Products Safe from Maltose Inaccuracy Risks 3
    (Date:8/22/2014)... Dealing with a drug or alcohol addiction is never ... child. Adolescent substance abuse has been an important issue among ... new helpline is now providing a valuable resource for teens ... like a teen drug addiction . , The ... positive impact in the community. By calling (513) 318-1603, parents ...
    (Date:8/22/2014)... Aid in Recovery, a full service drug ... a recent bill introduced in the Philippines ... legislator and retired police general. In House Bill 4451, ... rather than imprisonment. Aid in Recovery points to this ... the drug addiction epidemic. , The bill, introduced this ...
    (Date:8/21/2014)... Os-Monitor.com, an outstanding online supplier of useful software ... collection ( http://www.os-monitor.com ). In addition to that, ... high end items are offered with greatly discounted ... productivity, the employers pay more attention to their ... network monitoring software products are becoming more and ...
    (Date:8/21/2014)... Recently, Top10BestSEOHosting.com has compared many professional SEO hosting companies ... the most reliable suppliers for webmasters who want to ... boom in websites in recent years, and the new ... of web hosting companies that offer a variety of ... been providing hosting solutions to thousands of business and ...
    (Date:8/21/2014)... 2014 Recently, Skmen.com, a distinguished garment supplier, ... girls’ casual dresses . From today until August ... 30 percent off) when they are shopping at the company’s ... outfits are according to the newest quality standards; they are ... charming casual dresses, worldwide ladies can also access the other ...
    Breaking Medicine News(10 mins):Health News:Cincinnati’s New Troubled Teen Helpline is Making a Difference in the Community 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:New Employee Monitoring Software Collection Unveiled By Os-Monitor.com 2Health News:Best SEO Hosting Suppliers in the Global Market Recommended by Top10BestSEOHosting.com 2Health News:Charming Girls’ Casual Dresses Now Released by Distinguished Garment Company Skmen.com 2
    ... Royal Brisbane and Women's Hospital (RBWH), Sydney struggles with ... in three wards were found with a bacterium ... skin. ,To prevent the spread, 12 patients ... cent burns) were shifted to Sydney hospital and some ...
    ... medical colleges in West Bengal continued to be paralysed ... stir against the Centre's decision to introduce OBC quota ... interns, housestaff and post graduate trainees in nine medical ... dental colleges boycotted classes as well as out patient ...
    ... drugs, used by patients with enlarged hearts// (dilated ... Scientists with the Multicenter defibrillators in Nonischemic ... sudden cardiac deaths with cardiomyopathy due to a ... these about, 229 patients were randomly selected to ...
    ... A study conducted by Cancer Research UK says 'Teens who tried ... never tried it to take up smoking' //.Again after 3 years ... Research UK said anti-smoking campaigns should focus on preventing children trying ... found around 14% of 11-year olds and 62% of 15-year olds ...
    ... Ahmedabad-based Dishman Pharmaceuticals and Chemicals Ltd today said ... US-based Solutia Inc for 74.5 million dollars. // ... for purchasing 100 per cent stake in CarboGen ... in a statement., ,The acquisition includes other ...
    ... Ranbaxy Laboratories Limited today said the World Health Organistion ... (ARV) products in its pre-qualification list. // ... Efavirenz 200mg capsules, Stavudine 30mg capsules, Stavudine 40mg capsules, ... a significant development. We strongly feel that Generic ARVs ...
    Cached Medicine News:
    ... .90 mm (20 g) cannula ... mm in length. Cannula beveled ... 3201 has 16 cm (6 ... to allow injection of heavy ...
    PLX90S Sealed CO2 Laser System -- laser head + power supply....
    ... Ultra MD Super Pulse sealed CO2 surgical ... backed by the experience and support services ... of surgical laser experience. All settings are ... The Ultra MD Super Pulse surgical lasers ...
    ... Pulse sealed CO2 surgical lasers offer unmatched ... experience and support services of a company ... experience. All settings are available at the ... Super Pulse surgical lasers are compatible with ...
    Medicine Products: